SEC Form 4 · accession 0001209191-18-030889
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gabriel Leung
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 15, 2018 | M | 40,000 | $3.44 | A | 40,000 | D | |
| Ordinary SharesF1 | May 15, 2018 | S | 40,000 | $28.88 | D | 0 | D | |
| Ordinary Shares | May 16, 2018 | M | 100,000 | $3.44 | A | 100,000 | D | |
| Ordinary SharesF2 | May 16, 2018 | S | 40,000 | $28.77 | D | 60,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF3 | $3.44 | May 15, 2018 | M | 40,000 | A | — | Sep 15, 2021 | Ordinary Shares | 40,000 | 274,743 | D |
| Options to Buy Ordinary SharesF4 | $3.44 | May 16, 2018 | M | 100,000 | A | — | Sep 15, 2021 | Ordinary Shares | 100,000 | 174,743 | D |
Explanation of responses
- F1On May 15, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.80 to $28.98. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F2On May 16, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.65 to $28.94. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3Options to buy 40,000 ordinary shares are vested and currently exercisable as of the date hereof.
- F4Options to buy 100,000 ordinary shares are vested and currently exercisable as of the date hereof.